| Key Financial Ratios of Lincoln Pharmaceuticals (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
24.78 |
23.32 |
16.38 |
15.32 |
13.33 |
|
| Diluted EPS (Rs.) |
24.78 |
23.32 |
16.38 |
15.32 |
13.01 |
|
| Cash EPS (Rs.) |
27.52 |
25.78 |
18.58 |
15.63 |
15.30 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
152.25 |
131.30 |
109.77 |
94.79 |
85.03 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
152.25 |
131.30 |
109.77 |
94.79 |
85.03 |
|
| Dividend / Share(Rs.) |
1.50 |
1.50 |
1.50 |
1.20 |
1.00 |
|
| Revenue from Operations/Share (Rs.) |
188.04 |
176.52 |
162.48 |
152.14 |
190.56 |
|
| PBDIT/Share (Rs.) |
35.75 |
33.45 |
25.88 |
22.50 |
23.79 |
|
| PBIT/Share (Rs.) |
33.02 |
30.99 |
23.68 |
20.58 |
21.82 |
|
| PBT/Share (Rs.) |
32.02 |
29.07 |
21.55 |
17.87 |
18.43 |
|
| Net Profit/Share (Rs.) |
24.78 |
23.32 |
16.38 |
13.70 |
13.33 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
19.01 |
18.95 |
15.92 |
14.79 |
12.48 |
|
| PBIT Margin (%) |
17.55 |
17.55 |
14.57 |
13.52 |
11.45 |
|
| PBT Margin (%) |
17.02 |
16.46 |
13.26 |
11.74 |
9.67 |
|
| Net Profit Margin (%) |
13.17 |
13.21 |
10.08 |
9.00 |
6.99 |
|
| Return on Networth / Equity (%) |
16.27 |
17.75 |
14.92 |
14.45 |
15.67 |
|
| Return on Capital Employed (%) |
21.18 |
22.86 |
20.13 |
20.03 |
13.98 |
|
| Return on Assets (%) |
13.49 |
13.44 |
10.04 |
9.72 |
8.98 |
|
| Total Debt/Equity (X) |
0.01 |
0.12 |
0.25 |
0.27 |
0.42 |
|
| Asset Turnover Ratio (%) |
102.41 |
101.80 |
99.67 |
107.99 |
128.48 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.88 |
2.57 |
2.10 |
2.02 |
1.56 |
|
| Quick Ratio (X) |
3.21 |
2.18 |
1.69 |
1.60 |
1.27 |
|
| Inventory Turnover Ratio (X) |
10.02 |
11.98 |
8.90 |
9.55 |
12.60 |
|
| Dividend Payout Ratio (NP) (%) |
12.10 |
6.43 |
7.32 |
5.95 |
7.50 |
|
| Dividend Payout Ratio (CP) (%) |
10.90 |
5.81 |
6.45 |
5.21 |
6.53 |
|
| Earnings Retention Ratio (%) |
87.90 |
93.57 |
92.68 |
94.05 |
92.50 |
|
| Cash Earnings Retention Ratio (%) |
89.10 |
94.19 |
93.55 |
94.79 |
93.47 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
260.74 |
449.46 |
466.93 |
517.75 |
309.80 |
|
| EV/Net Operating Revenue (X) |
0.69 |
1.27 |
1.44 |
1.70 |
1.00 |
|
| EV/EBITDA (X) |
3.65 |
6.72 |
9.02 |
11.50 |
7.98 |
|
| MarketCap/Net Operating Revenue (X) |
0.71 |
1.20 |
1.29 |
1.55 |
0.82 |
|
| Retention Ratios (%) |
87.89 |
93.56 |
92.67 |
94.04 |
92.49 |
|
| Price/BV (X) |
0.88 |
1.62 |
1.92 |
2.49 |
1.85 |
|
| Price/Net Operating Revenue |
0.71 |
1.20 |
1.29 |
1.55 |
0.82 |
|
| Earnings Yield |
0.19 |
0.11 |
0.08 |
0.06 |
0.08 |
|
Source : Dion Global Solutions Limited
